Life Healthcare expects NEPS up between 6% and 10% for H1 FY26, to between 52.0c and 53.9c. Revenue increased between 2.2% and 2.6%, despite a R130m impact from a funder placed under curatorship. PPDs fell around -0.4%, while occupancy declined to 67.5% from 68.8%, although activity trends improved in Q2 with stronger theatre volumes. EBITDA increased between 4.9% and 5.3%, supported by operational efficiencies and margin improvement initiatives.
Click here to read the SENS